Therapy of Pemphigus Vulgaris
- 1 January 1999
- journal article
- editorial
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 135 (1) , 76-78
- https://doi.org/10.1001/archderm.135.1.76
Abstract
HOW SHOULD a patient with pemphigus vulgaris (PV) be treated? Unfortunately, there is no easy answer to this question for several reasons. First, there is not oKeywords
This publication has 20 references indexed in Scilit:
- Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy?British Journal of Dermatology, 1998
- The adjuvant therapy of pemphigus. An updateArchives of Dermatology, 1996
- The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: Preliminary studyJournal of the American Academy of Dermatology, 1994
- Pemphigus. Skin failure mediated by autoantibodiesJAMA, 1990
- Effect of plasmapheresis therapy on circulating levels of pemphigus antibodiesJournal of the American Academy of Dermatology, 1990
- Treatment of nine cases of pemphigus vulgaris with cyclosporineJournal of the American Academy of Dermatology, 1988
- Use of cyclophosphamide in azathioprine failures in pemphigusJournal of the American Academy of Dermatology, 1987
- Plasma exchange in pemphigus. Uncontrolled study of ten patientsArchives of Dermatology, 1983
- Pemphigus: a 20-year review of 107 patients treated with corticosteroidsArchives of Dermatology, 1976
- Management of pemphigus with gold compounds: a long-term follow-up reportArchives of Dermatology, 1976